Panel of Federal Judges Consolidate Pradaxa Cases to Illinois
/EINPresswire.com/ According to an order entered today, all Pradaxa cases in the federal court system, now pending and filed in the future, will be consolidated in front of Judge Herndon in the Southern District of Illinois
Today, the Joint Panel on Multidistrict Litigation, a panel of federal judges that manages coordination of mass cases, entered an order consolidating all current and future federally-filed cases involving the blood thinner Pradaxa in front of Judge David R. Herndon, chief judge of the Southern District of Illinois.
Given the complexity of this litigation and anticipated resource demands that accompany "mass tort" (multiple plaintiffs injured in a similar fashion by a defective product) cases, the consolidation is intended to "promote the just and efficient conduct of the litigation." According to the order, the consolidation is proper because, "all the actions share common factual questions arising out of allegations that plaintiffs suffered severe bleeding or other injuries as a result of taking the drug Pradaxa."
Judge Herndon is an experienced MDL judge who should prove to be fair to all parties involved in the litigation. Based on his work presiding over the Yaz and Yasmin litigation (another large pharmaceutical products liability litigation), we believe that Judge Herndon will move this litigation forward expeditiously, which is in the best interest of the injured patients, most of whom are elderly.
Pradaxa was approved in late 2010 for the prevention of stroke among patients with non-valvular atrial fibrillation. Marketed as a therapeutic simplification to a drug that had been on the market for 60 years, Coumadin, Pradaxa has achieved blockbuster status by generating sales of more than one billion dollars a year. Pradaxa was designed to thin blood and reduce blood clots, which can cause strokes. Yet, in less than two years since its release, Boehringer Ingelheim's anticoagulant has been the subject of FDA Safety announcements and nearly 15,000 adverse events reported through the first quarter of 2012.
The attorneys at TorHoerman Law have been working diligently to move the Pradaxa litigation forward. TorHoerman Law cases were among the first filed cases in the Southern District of Illinois. Last week, Judge Herndon ruled in favor of our plaintiffs by denying motions to dismiss filed by Boeheringer Ingelheim.
After receiving word of the consolidation, Steven Davis, attorney at TorHoerman Law stated "we are pleased with the panel's decision today and look forward to the opportunity to see that justice is done for those injured as a result of taking Pradaxa."
If you or a family member has been prescribed Pradaxa and have suffered bleeding complications, consult your doctor immediately. TorHoerman Law is also urging anyone that experienced serious complications while on Pradaxa to contact an experienced attorney soon to investigate whether you have a right to compensation for your injuries.
TorHoerman Law is a national drug, medical device and toxic tort litigation firm. Representing clients in 50 states, we are not afraid to take on the largest companies when they put profits ahead of safety.
Jessie Hoerman
TorHoerman Law
618-656-4400
http://www.torhoermanlaw.com
PR Courtesy of Online PR Media
Today, the Joint Panel on Multidistrict Litigation, a panel of federal judges that manages coordination of mass cases, entered an order consolidating all current and future federally-filed cases involving the blood thinner Pradaxa in front of Judge David R. Herndon, chief judge of the Southern District of Illinois.
Given the complexity of this litigation and anticipated resource demands that accompany "mass tort" (multiple plaintiffs injured in a similar fashion by a defective product) cases, the consolidation is intended to "promote the just and efficient conduct of the litigation." According to the order, the consolidation is proper because, "all the actions share common factual questions arising out of allegations that plaintiffs suffered severe bleeding or other injuries as a result of taking the drug Pradaxa."
Judge Herndon is an experienced MDL judge who should prove to be fair to all parties involved in the litigation. Based on his work presiding over the Yaz and Yasmin litigation (another large pharmaceutical products liability litigation), we believe that Judge Herndon will move this litigation forward expeditiously, which is in the best interest of the injured patients, most of whom are elderly.
Pradaxa was approved in late 2010 for the prevention of stroke among patients with non-valvular atrial fibrillation. Marketed as a therapeutic simplification to a drug that had been on the market for 60 years, Coumadin, Pradaxa has achieved blockbuster status by generating sales of more than one billion dollars a year. Pradaxa was designed to thin blood and reduce blood clots, which can cause strokes. Yet, in less than two years since its release, Boehringer Ingelheim's anticoagulant has been the subject of FDA Safety announcements and nearly 15,000 adverse events reported through the first quarter of 2012.
The attorneys at TorHoerman Law have been working diligently to move the Pradaxa litigation forward. TorHoerman Law cases were among the first filed cases in the Southern District of Illinois. Last week, Judge Herndon ruled in favor of our plaintiffs by denying motions to dismiss filed by Boeheringer Ingelheim.
After receiving word of the consolidation, Steven Davis, attorney at TorHoerman Law stated "we are pleased with the panel's decision today and look forward to the opportunity to see that justice is done for those injured as a result of taking Pradaxa."
If you or a family member has been prescribed Pradaxa and have suffered bleeding complications, consult your doctor immediately. TorHoerman Law is also urging anyone that experienced serious complications while on Pradaxa to contact an experienced attorney soon to investigate whether you have a right to compensation for your injuries.
TorHoerman Law is a national drug, medical device and toxic tort litigation firm. Representing clients in 50 states, we are not afraid to take on the largest companies when they put profits ahead of safety.
Jessie Hoerman
TorHoerman Law
618-656-4400
http://www.torhoermanlaw.com
PR Courtesy of Online PR Media
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.